Visitor Monitoring Drug Details: COUMADIN
 
Drugs Directory of False Positives DRUGS THAT CAUSES A FALSE POSITIVE ON A DRUG TEST
 
Browse by Letter: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Drug Details

Drug Name: COUMADIN
FDA Application No: (NDA) 009218
Active Ingredient(s): WARFARIN SODIUM
Company: BRISTOL MYERS SQUIBB
Original Approval or Tentative Approval Date: June 8, 1954
Chemical Type: 1 New molecular entity (NME)
Review Classification: S Standard review drug
 
Therapeutic Equivalents Label Information
Approval History, Letters, Reviews and Related Documents
 
You can see the products in the same application. The table can be sorted by clicking the header columns.
 
Drug NameSort imageActive IngredientsStrengthDosage Form/RouteMarketing StatusRLDTE Code
COUMADIN WARFARIN SODIUM10MGTABLET; ORAL Prescription Yes AB
COUMADIN WARFARIN SODIUM5MGTABLET; ORAL Prescription No AB
COUMADIN WARFARIN SODIUM75MG/VIALINJECTABLE; INJECTION Discontinued No None
COUMADIN WARFARIN SODIUM2MGTABLET; ORAL Prescription No AB
COUMADIN WARFARIN SODIUM7.5MGTABLET; ORAL Prescription No AB
COUMADIN WARFARIN SODIUM2.5MGTABLET; ORAL Prescription No AB
COUMADIN WARFARIN SODIUM50MG/VIALINJECTABLE; INJECTION Discontinued No None
COUMADIN WARFARIN SODIUM1MGTABLET; ORAL Prescription No AB
COUMADIN WARFARIN SODIUM4MGTABLET; ORAL Prescription No AB
COUMADIN WARFARIN SODIUM5MG/VIALINJECTABLE; INJECTION Prescription Yes None
COUMADIN WARFARIN SODIUM3MGTABLET; ORAL Prescription No AB
COUMADIN WARFARIN SODIUM6MGTABLET; ORAL Prescription No AB


Comments for COUMADIN
 
 
Name: *
 
Email: *
 
Text:
(HTML OK)
 
Enter the code from the picture: *
(click here to load another image)
 
 
  
There are no comments.
©2019 Drugs That Causes a False Positive on a Drug Test